NCT07569172

Brief Summary

The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:

  • Does the social transfer increase complementary breastfeeding rates at 24-months postpartum?
  • Does the social transfer increase complementary breastfeeding duration?
  • Does the social transfer impact child health and development?
  • Does the social transfer impact maternal physical and mental health? Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding. Participants will: Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,040

participants targeted

Target at P75+ for not_applicable

Timeline
21mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 6, 2026

Completed
26 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2028

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

April 15, 2026

Last Update Submit

April 28, 2026

Conditions

Keywords

breastfeedingcash transferchild healthmaternal healthmental healthchild growthchild developmenteducation

Outcome Measures

Primary Outcomes (2)

  • Prevalence of Complementary Breastfeeding

    Prevalence of complementary breastfeeding at 24 months postpartum.

    from 12 to 24 months postpartum

  • Complementary Breastfeeding Duration

    Duration of complementary breastfeeding in weeks.

    from 12 to 24 months postpartum

Secondary Outcomes (16)

  • Weight-for-Age z-score

    12 months; 24 months

  • Child Health Outcomes

    12 months; 24 months

  • Percent weight loss

    12 months; 24 months;

  • Mother and Child Hemoglobin Levels

    12 months; 24 months

  • Maternal Depression

    12 months; 24 months

  • +11 more secondary outcomes

Study Arms (2)

Social Transfer

EXPERIMENTAL

A social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations.

Other: Social Transfer

Control

NO INTERVENTION

No intervention is provided besides education on current breastfeeding recommendations.

Interventions

A social transfer will be given conditioned upon breastfeeding at 24-months postpartum.

Social Transfer

Eligibility Criteria

Age12 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Are enrolled in the Taabo multigenerational birth cohort (MGC)
  • Completed the postpartum interview of the Taabo MGC
  • Have a child who is within two weeks of their 12-month birthday,
  • are breastfeeding at time of recruitment,
  • live in the Taabo HDSS, Côte d'Ivoire
  • have no illnesses that contraindicates breastfeeding,
  • had a healthy singleton infant with a birth weight of at least 2500 grams, and
  • agree to participate and sign an informed consent; if underage (12-17 years), a legal representative will also have to agree to sign the informed consent

You may not qualify if:

  • Plans to move permanently outside study area
  • Has a medical, intellectual or psychological disability
  • Contraindication for breastfeeding
  • Children born with \< 2500 grams

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taabo Health and Demographic Surveillance

Taabo, Côte d’Ivoire

Location

MeSH Terms

Conditions

Breast FeedingCommunicable DiseasesAnemiaWeight LossPsychological Well-BeingDiarrheaCoughEczemaHypersensitivity

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorInfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsHematologic DiseasesHemic and Lymphatic DiseasesBody Weight ChangesBody WeightSigns and SymptomsPersonal SatisfactionSigns and Symptoms, DigestiveRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratoryDermatitisSkin DiseasesSkin and Connective Tissue DiseasesSkin Diseases, EczematousImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project Leader

Study Record Dates

First Submitted

April 15, 2026

First Posted

May 6, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

February 28, 2028

Study Completion (Estimated)

February 28, 2028

Last Updated

May 6, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE

Locations